PMID- 11726345
OWN - NLM
STAT- MEDLINE
DCOM- 20011226
LR  - 20131121
IS  - 0029-6465 (Print)
IS  - 0029-6465 (Linking)
VI  - 36
IP  - 4
DP  - 2001 Dec
TI  - Deep vein thrombosis and anticoagulant therapy.
PG  - 645-63, v
AB  - This article focuses on deep vein thrombosis (DVT) and anticoagulant therapy. The 
      risk factors, pathophysiology, prevention, and detection of DVT are explained. 
      Anticoagulants such as unfractionated heparin (UFH), low molecular weight heparin 
      (enoxaparin), and warfarin are discussed. The article also reviews nursing 
      assessment and monitoring of patients with DVT as well as patient education on 
      anticoagulants.
FAU - Sullano, M A
AU  - Sullano MA
AD  - Division of Nursing, The University of Texas M. D. Anderson Cancer Center, 
      Houston, Texas 77030, USA.
FAU - Ortiz, E J
AU  - Ortiz EJ
LA  - eng
PT  - Journal Article
PT  - Patient Education Handout
PT  - Review
PL  - United States
TA  - Nurs Clin North Am
JT  - The Nursing clinics of North America
JID - 0042033
RN  - 0 (Anticoagulants)
RN  - 5Q7ZVV76EI (Warfarin)
RN  - 9005-49-6 (Heparin)
SB  - IM
MH  - Anticoagulants/*therapeutic use
MH  - Drug Interactions
MH  - Heparin/adverse effects/analogs & derivatives/*therapeutic use
MH  - Humans
MH  - Nursing Assessment
MH  - Risk Factors
MH  - Venous Thrombosis/diagnosis/*drug therapy/nursing
MH  - Warfarin/adverse effects/*therapeutic use
RF  - 22
EDAT- 2001/12/01 10:00
MHDA- 2002/01/05 10:01
CRDT- 2001/12/01 10:00
PHST- 2001/12/01 10:00 [pubmed]
PHST- 2002/01/05 10:01 [medline]
PHST- 2001/12/01 10:00 [entrez]
PST - ppublish
SO  - Nurs Clin North Am. 2001 Dec;36(4):645-63, v.